Aptalis Pharma™ Launches PYLERA® in France: A Therapeutic Alternative for Eradicating Helicobacter Pylori and Preventing Relapse of H. Pylori Associated Peptic Ulcers

BRIDGEWATER, NJ--(Marketwired - Apr 11, 2013) - Aptalis Pharma, US Inc. announced that its French sister company, Aptalis Pharma SAS, has launched PYLERA® to healthcare professionals in France...

Click here to read the full press release.

© 2012 Aptalis. All rights reserved.
Site Map   |   Terms & Conditions   |   Privacy Policy   |   California Declaration   |   Aptalis Code of Conduct

Last Updated: April 11, 2013